Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Dosing for Childhood Uveitis
NCT00589628Phase 4Completed
- Start
- Sep 2007
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in uveitis. Started Sep 2007; status: completed.
02
Drugs
infliximab
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT00589628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589628.